hemevolution.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Patient
Description STEP INTO A WORLD OF ELEVATED FACTOR IX LEVELS THAT LAST FOR HEMGENIX is the first and only FDA-approved gene therapy for hemophilia B. It is a one-time infusion that offers elevated factor IX levels for
Keywords N/A
Server Information
WebSite hemevolution faviconhemevolution.com
Host IP 12.3.33.225
Location United States
Related Websites
Site Rank
More to Explore
hemevolution.com Valuation
US$1,029,009
Last updated: 2023-05-18 14:00:33

hemevolution.com has Semrush global rank of 10,285,924. hemevolution.com has an estimated worth of US$ 1,029,009, based on its estimated Ads revenue. hemevolution.com receives approximately 118,732 unique visitors each day. Its web server is located in United States, with IP address 12.3.33.225. According to SiteAdvisor, hemevolution.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,029,009
Daily Ads Revenue US$950
Monthly Ads Revenue US$28,496
Yearly Ads Revenue US$341,948
Daily Unique Visitors 7,916
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
hemevolution.com. A 7198 IP: 12.3.33.225
hemevolution.com. NS 21600 NS Record: dmtu.mt.ns.els-gms.att.net.
hemevolution.com. NS 21600 NS Record: dbru.br.ns.els-gms.att.net.
hemevolution.com. TXT 21600 TXT Record: w5ff2bf97ftrfqwmdgpjs9kc9ynmp0vw
HtmlToTextCheckTime:2023-05-18 14:00:33
You are now leaving the current website. The site you are accessing is maintained by a third party over whom CSL Behring has no control. CSL Behring does not review, approve, or necessarily endorse viewpoints, inferences, or conclusions stated in or implied by the content of this site. CSL Behring is not responsible for third-party content or the consequences of your use thereof. Do you want to continue? No Yes X Prescribing Information Important Safety Information For Healthcare Professionals Why Gene Therapy About HEMGENIX Results With HEMGENIX Safety How HEMGENIX Works Steps to Treatment Patient Support Patient Services Resources and FAQs For Healthcare Professionals Facebook Instagram Stay informed David Factor IX level of 37% at 2 years Patient portrayal; HEMGENIX not intended for women HEMGENIX: The first and only FDA-approved gene therapy for hemophilia B STEP INTO A WORLD OF ELEVATED FACTOR IX LEVELS THAT LAST FOR YEARS A one-time infusion delivers greater bleed protection*
HTTP Headers
HTTP/1.1 301 Moved permanently
Location: https://hemevolution.com/
Connection: close
Cache-Control: no-cache
Pragma: no-cache

HTTP/1.1 301 Moved Permanently
Content-Length: 239
Content-Type: text/html
Location: https://www.hemevolution.com/
Server: Microsoft-IIS/8.5
X-Powered-By: ASP.NET
CSL-Asset: W42
X-Frame-Options: SAMEORIGIN
Date: Thu, 23 Jun 2022 09:19:16 GMT
Strict-Transport-Security: max-age=157680000

HTTP/1.1 200 OK
Cache-Control: private
Content-Length: 23634
Content-Type: text/html; charset=utf-8
Server: Microsoft-IIS/8.5
X-AspNetMvc-Version: 5.2
X-AspNet-Version: 4.0.30319
Set-Cookie: visitor_type=PATIENT; path=/
X-Powered-By: ASP.NET
CSL-Asset: W43
X-Frame-Options: SAMEORIGIN
Date: Thu, 23 Jun 2022 09:19:17 GMT
Strict-Transport-Security: max-age=157680000
Set-Cookie: NSC_mcwt_xxx.IfnFwpmvujpo.dpn=ffffffffaf1c1fb045525d5f4f58455e445a4a423660;Version=1;path=/;secure;httponly
hemevolution.com Whois Information
Domain Name: HEMEVOLUTION.COM
Registry Domain ID: 2650198678_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2021-10-25T18:06:02Z
Creation Date: 2021-10-25T18:06:01Z
Registry Expiry Date: 2023-10-25T18:06:01Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2086851750
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: DBRU.BR.NS.ELS-GMS.ATT.NET
Name Server: DMTU.MT.NS.ELS-GMS.ATT.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-06-23T09:25:44Z <<<